B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
Blast crisis (BC) is one of the most dreaded complications of chronic myeloid leukemia (CML). Fortunately, the incidence of BC has diminished markedly in the <i>BCR-ABL</i> tyrosine kinase inhibitor (TKI) era. The primary objective of initial treatment in BC is to achieve a second chroni...
Main Authors: | Binoy Yohannan, Binsah George |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/19/11836 |
Similar Items
-
Two Cases of Chronic Myeloid Leukemia in Lymphoid Blast Phase Presented as Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Tae Hoon Lee, et al.
Published: (2023-10-01) -
Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
by: C. B. Almeida, et al.
Published: (2016-11-01) -
Spontaneous Remission in a Patient with Chronic Myeloid Leukemia: A Case Report
by: Awni Alshurafa, et al.
Published: (2023-10-01) -
Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis
by: Olivia Kronick, et al.
Published: (2023-08-01) -
A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
by: Gamal Abdul Hamid, et al.
Published: (2014-03-01)